Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD before psychotherapy waiting-list treatment for anxiety symptoms in uniformed personnel
NL-OMON52231Phase 2Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anxiety disorder and post-traumatic stress disorder (PTSD) comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Change in anxiety symptoms. Started Feb 2022; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
anxiety disorderpost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON52231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52231.